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Abstract
Extended Spectrum b-Lactamase (ESBL) producing Enterobacteriaceae started to appear in the 1980s, and have since
emerged as some of the most significant hospital-acquired infections with Escherichia coli and Klebsiella being main players.
More than 100 different ESBL types have been described, the most widespread being the CTX-M b-lactamase enzymes
(blaCTX-M genes). This study focuses on the zoonotic dissemination of ESBL bacteria, mainly CTX-M type, in the southern
coastal region of France. We found that the level of general antibiotic resistance in single randomly selected E. coli isolates
from wild Yellow-legged Gulls in France was high. Nearly half the isolates (47,1%) carried resistance to one or more
antibiotics (in a panel of six antibiotics), and resistance to tetracycline, ampicillin and streptomycin was most widespread. In
an ESBL selective screen, 9,4% of the gulls carried ESBL producing bacteria and notably, 6% of the gulls carried bacteria
harboring CTX-M-1 group of ESBL enzymes, a recently introduced and yet the most common clinical CTX-M group in France.
Multi locus sequence type and phylogenetic group designations were established for the ESBL isolates, revealing that birds
and humans share E. coli populations. Several ESBL producing E. coli isolated from birds were identical to or clustered with
isolates with human origin. Hence, wild birds pick up E. coli of human origin, and with human resistance traits, and may
accordingly also act as an environmental reservoir and melting pot of bacterial resistance with a potential to re-infect
human populations.
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Introduction
The levels of antibiotic resistance in Escherichia coli have reached
a point where they pose severe clinical challenges to humans. E.
coli is frequently used for studies of resistance status and
development, and displays a relatively rapid transfer of resistance
between strains, particularly if plasmid-borne [1,2]. It is also a
major player in the spread of the recently emerged resistance to b-
lactam antibiotics through the action of CTX-M b-lactamases,
enzymes that have their origin in chromosomally located genes of
other members of the Enterobacteriaceae family, i.e. Kluyvera sp.
and possibly others [1]. Enterobacteriaceae that produce extended
spectrum b-lactamases (ESBLs) started to appear in the 1980s, and
have since emerged as some of the most significant hospital-
acquired infections [1]. ESBL-producing bacteria, mainly E. coli
and Klebsiella, are rapidly increasing among human isolates and
today more than 100 different ESBL types have been described,
with the most widespread type being the CTX-M b-lactamase
enzymes (hereafter CTX-M) encoded by the blaCTX-M gene. The
first CTX-M was characterized in 1989, but today CTX-M have a
large geographical distribution [1,3]. In France reports of CTX-M
emergence arose with the new century and several outbreaks were
described in northern France 2002–2003. In southern France,
other types of ESBL accounted for .90% of the ESBLs in a 2002–
2003 survey. In this region, CTX-M started to appear later but
have from 2004 been identified in several hospitals [3]. The CTX-
M has also spread to other microorganisms, including community
species such as Salmonella, Shigella and Vibrio cholera [3].
Migrating birds seem to act as transporters, or as reservoirs, of
resistant bacteria and could therefore have an important
epidemiological role in the dissemination of resistance, as well as
being mirrors of the spectrum of pathogenic micro-organisms
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shown by the finding of a higher E. coli presence in wild birds with
human association than in birds lacking human contacts [4].
Furthermore, although animals isolated from human activities
previously displayed lower levels of resistant bacteria [5], more
recent studies now show the presence of resistant E. coli in wild
birds regardless of isolation. We saw e.g. that E. coli in Arctic birds
sampled at the Siberian tundra carried antibiotic resistance, an
indication of worldwide resistance dissemination [6]. In Maryland,
US, migratory geese were carriers of resistant E. coli, as were
Black-headed Gulls in the Czech Republic [7,8]. E. coli harboring
b -lactamases of CTX-M, TEM and SHV type have previously
been detected in birds of prey and seagulls in Portugal [9,10].
We investigated the presence of antibiotic resistance, with special
focus on CTX-M ESBL bacteria, in Yellow-legged Gulls (Larus
michahellis) in two populations in Camargue, southern France
(Figure 1).Thisspeciesbelongstothe Herring Gull-complex,a setof
large size gulls including several species present in the northern
hemisphere. Many of these gulls, including the Yellow-legged Gull,
have increased in numbers and distribution due to their custom of
living in proximity to humans. They are often opportunistic marine
feeders, seeking their food (fish, bivalves, mollusks, eggs, birds etc)
along the shoreline or offshore, but also readily utilizing the food
sources provided by humans, especially garbage. The two Yellow-
legged Gull populations are located in a region with a dense human
population, and were chosen in order to take into account any
variations in resistance patterns resulting from differences in the
availability of human-associated food sources. The gulls breeding at
Port Saint-Louis Carteau colony feed mainly at Marseille city
dump, whereas the gulls at Aigues-Mortes colony feed mainly
offshore (Figure 1). Our results show that resistance levels of
randomly selected E. coli (one strain from each sample) are high
when measured against a panel of six antibiotics, and that wild birds
in this region carry high levels of ESBL producing bacteria
displaying genotypes highly related with French (human) clinical
samples. Further, ESBL producing E. coli from these birds shared
phylogenetic diversity with human E. coli, coherent with that these
bacteria are established zoonotic agents.
Results
Antibiotic resistance-levels in E. coli from Yellow-legged
Gulls
In order to determine a general picture of resistance levels in
Yellow-legged Gulls we tested one randomly selected E. coli isolate
per sample, to a panel of six antibiotics. Nearly half (47.1%; 72/153
isolates) of the E. coli isolates were resistant to at least one antibiotic,
and there was no difference in overall resistance rates between the
Figure 1. Map shows location of Yellow-legged Gull populations in the study. Port Saint-Louis Carteau colony feeds mainly at the Marseille
city dump, and Aigues-Mortes colony mainly offshore.
doi:10.1371/journal.pone.0005958.g001
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39/78 isolates from ‘‘off shore’’ colony). Resistance to two or more
antimicrobial agents was widespread, and found in approximately
1/3ofthe isolates.Themostwidespreadresistancephenotypeswere
those resistant to tetracycline, ampicillin and streptomycin.
Resistances to the remaining compounds were less frequent
(Table 1). Four strains displayed resistance to cefadroxil (Table 1),
an indication of potential ESBL carriage.
Selective screen for ESBL producing bacteria
ESBL producing bacteria were initially identified by phenotypic
tests. 17 isolates (16 E. coli and one Enterobacter cloacae, all from
separate samples) were found that exhibited disc diffusion synergy
test and cefepime MIC concordant with ESBL production, as well
as growth on cefpodoxime containing chromID
TM ESBL plates.
The presence of blaCTX-M, blaTEM and blaSHV was then
determined by PCR. Ten isolates were confirmed to harbor
CTX-M-1-group enzymes, and sequencing defined genotypes to 9
isolates (including the E. cloacae) with blaCTX-M-1 and one with
blaCTX-M-15 (Table 2). blaTEM was found in combination with
blaCTX-M in two isolates and with blaSHV in two isolates, and
separately in five isolates. All isolates, containing any of the bla-
genotypes, displayed ESBL positive results in Etests with
cefotaxime, ceftazidime and cefepime combined with clavulanic
acid inhibition. Three of the four fecal samples containing
cefadroxil resistant, randomly selected, E. coli also generated
ESBL producing bacteria in the ESBL selective screen (E. coli with
sample ID 63638, 63654, and 63725; Table 2).
Multi locus sequence typing and phylogenetic group
determination of the ESBL producing isolates
Based on sequencing of 3423 nucleotides at seven house-
keeping genes, the sixteen ESBL-producing E. coli were assigned to
13 different sequence types (STs) (Table 3). Nine isolates were
assigned to seven novel STs, i.e., allelic profiles that were not found
in the multi locus sequence typing (MLST) database; STX1 (1
isolate), STX2 (2 isolates), STX3 (1 isolates), STX4 (1 isolate),
STX5 (2 isolates), STX6 (1 isolate), and STX7 (1 isolate) (Table 3).
Seven isolates were assigned to six previously reported STs; single
isolates to ST156, ST90, ST351 or ST746, respectively, and two
isolates to ST681. The 13 STs representing the 16 ESBL-
producing E. coli isolates were compared with 273 STs
representing full global diversity of the species (Figure 2) [11]. It
was apparent that the 16 ESBL isolates covered a broad range of
genetic diversity. Consequently, a large fraction of the currently
known E. coli genetic diversity was present among the ESBL-
producing isolates and they were not of recent common ancestry.
Specifically, only those isolates that are found in a clonal complex
or share an ST are likely to have a recent common ancestry, i.e.,
isolates in STX2, in STX5, or in ST681.
According to the classification method by Clermont et al. [12],
later modified by Escobar-Pa ´ramo et al. by addition of subgroups
[13], seven isolates belonged to phylogenetic group A0, five to
group D, one to group B1, two to group B2, and one to group A
(Table 3). The seven isolates classified as A0 were not closely
related as determined by MLST, they were frequently found
interleaved among isolates of other phylogroups and were widely
dispersed in the minimum spanning tree (Figure 2). For other
phylogenetic groups, there was some correspondence with the
position of a corresponding ST in the minimum spanning tree, e.g.
isolates of STX5 shared phylogroup D with other neighbor isolates
and ST681 shared the B2 phylogroup with its neighbors (Figure 2).
Phylogroup assignments within STs were consistent, isolates
assigned to the same ST always shared phylogenetic group. The
blaCTX-M harboring E. coli were widely dispersed out in the
minimum spanning tree showing that these resistance genes are
present across the full E. coli genetic diversity.
Discussion
In the Mediterranean region, including France, the usage of
antibiotics in human and veterinary medicine is at a comparatively
high level [14], and consequently we found a high general level of
antibiotic resistance in E. coli from Yellow-legged Gulls in the
Marseille region. We believe that the influence of antibiotics in the
region has been such that wild bird populations with varied
Table 1. Antibiotic resistance of single randomly selected E.
coli isolates from bird fecal samples.
Antibiotic Colony by feeding site
‘‘City Dump’’ (n=75) ‘‘Offshore’’ (n=78)
Tetracycline 27 32
Ampicillin 19 19
Streptomycin 15 14
Chloramphenicol 2 8
Nalidixic acid 2 2
Cefadroxil
1 40
1Cefadroxil resembles cefalexin and is used to screen for ESBLs as part of the
recommendations by the SRGA.
doi:10.1371/journal.pone.0005958.t001
Table 2. Genotypic analyses of phenotypically positive ESBL
producing bacteria.
Isolate ID Species bla-genotype
CTX-M
a TEM
c SHV
b
‘‘Offshore’’ 63541 E. coli 21
63546 E. coli ++
63560 E. coli +
63562 E. coli 215 +
63574 E. coli ++
‘‘City Dump’’ 63606 E. coli 21
63633 E. coli 21
63638 E. coli 21
63652 E. coli +
63654 E. coli 21
63657 E. coli +
63659 E. coli 21
63686 E.cloacae 21
63688 E. coli 21 +
63706 E. coli +
63725 E. coli 21
63727 E. coli +
ablaCTX-M positive isolates were sequenced for specific genotypes, see methods
and materials.
b+ indicates presence of blaTEM and blaSHV genes as detected by real-time PCR,
see methods and materials.
doi:10.1371/journal.pone.0005958.t002
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levels. In fact, the resistance patterns are similar, with high level
resistance especially to tetracycline, streptomycin and ampicillin.
These are common resistance types in domesticated and wild
animals in contact with human activities [2,9].
Of 17 (9.4%) ESBL type b-lactam resistant isolates, all 10 CTX-
M type isolates (nine E. coli, one E. cloacae) belonged to the CTX-
M-1 group, specifically nine of blaCTX-M-1 (including the E. cloacae)
genotype and one blaCTX-M-15. This is consistent with French
clinical (human) isolates, where the CTX-M-1 group is also the
major type [15], and both blaCTX-M-1 and blaCTX-M-15 genotypes
have been isolated [1]. One isolate was E. cloacae, often a clinically
relevant species as well [15,16]. Nine blaTEM and two blaSHV
harboring isolates were present, all positive in phenotypic tests for
ESBL. Two isolates included both blaCTX-M and blaTEM, and two
both blaTEM and blaSHV.
We found that fecal samples from gull colonies contained a high
prevalence of E. coli with antibiotic resistance traits and that ESBL
producing isolates exhibited great genetic diversity. This suggests
that dense bird colonies, such as the Yellow-legged Gulls in our
study, might serve as melting pots for creation of new E. coli
variants carrying antibiotic resistance, or alternatively, that these
birds are remarkably effective samplers of genetically diverse
ESBL-carrying E. coli from other sources, e.g. humans. The
distribution pattern of ESBL producing isolates within the genetic
structure of E. coli shows that not only a few sporadic imports of
specific clones carrying antibiotic resistance has occurred.
Regardless of where the ESBL-producing E. coli have evolved
originally, the feeding habit of gulls creates opportunities for
Table 3. MLST and phylogenetic group assignments for ESBL-
producing E. coli isolates.
Isolate ID ST
Clonal
complex Phylogenetic group
a
63541 ST1199 – B1
63546 ST533 – A0
b
63560 ST1140 – D
63562 ST156 ST156 A0
63574 ST90 ST23 A
63606 ST1142 – A0
63633 ST681 – B2
63638 ST681 – B2
63652 ST1134 – A0
63654 ST1143 – D
63657 ST1135 – D
63659 ST1144 ST746 A0
63688 ST1140 – D
63706 ST746 ST746 A0
63725 ST1143 – D
63727 ST351 – A0
aPhylogentic group as determined by the triplex PCR method (ref Clermont).
bA0 denotes that all three DNA targets of the triplex PCR failed to amplify.
doi:10.1371/journal.pone.0005958.t003
Figure 2. Distribution of 16 ESBL producing E. coli isolates within a minimum spanning tree representing 273 previously reported
STs (dots) from a collection of 459 diverse E. coli isolates. The tree is based on the degree of allele sharing by MLST analysis. Clonal complexes
composed of at least three ST members are indicated by dots proportional in size to the number of STs within them. STs, isolate designations,
phylogenetic group, and distribution of CTX-M genes of ESBL producing E. coli from birds are indicated (black dots). Uniformly colored dots indicate a
shared phylogenetic group. Thick lines connecting pairs of STs indicate that they share six (thick lines) or five (thin lines) alleles. Dotted connecting
lines represent less allele sharing.
doi:10.1371/journal.pone.0005958.g002
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genetic backgrounds.
We noted a lack of association between phylogenetic group and
the allele based population structure analysis by MLST (Figure 2).
Our findings are consistent with recent findings of other workers.
Gordon et al. found that E. coli isolates that fail to produce any
PCR amplicon at the three genes targeted in the triplex PCR assay
(group A0 isolates [13]) are genetically heterogeneous [17].
Accordingly, our seven A0 isolates were genetically diverse
illustrating that the A0 phylogenetic group assignment is a poor
predictor of genetic relatedness.
IsolatesassignedtothesameSTsorSTcomplexarelikelytohave
a common recent ancestor. Our findings in bird samples of E. coli of
STs that have been recovered from humans might therefore
indicate transmission between man and birds. We found an ESBL-
producing member of the ST23 clonal complex (Figure 2), which
has previously been reported for several pathogenic E. coli isolates of
human origin. Isolates of the ST23 clonal complex were reported
from urinary tract infections in California, Toulouse in France, and
from the northwest of England [18,19]. The isolate from England
was, similar to our bird isolate, resistant to expanded-spectrum
cephalosporins. Similarly, we recovered an ESBL producing E. coli
of ST533, an ST previously reported for an isolate from a human
urinary tract infection in Brazil and exhibiting blatem-1 and blaCTX-
M-2 genes. This data together with data from other studies support
the fact that E. coli with or without antibiotic resistance traits are
transmitted between humans and birds [20,21].
To summarize, we believe that a high general resistance level in
Yellow-legged Gulls in the south of France is a result of long-time
direct or indirect exposure to human activities in an area with
relatively high antibiotic pressure. The presence of ESBL producing
Enterobacteriaceae is high (9.4%) and in particular the proportion
of the CTX-M-1 group (6%), which in this region is a very recently
emerged and rapidly increasing ESBL type. The fact that ESBL
producing bacteria are phylogenetically dispersed among E. coli
isolates of human clinical and animal origin, underlines our
hypothesis that these bacteria are both zoonotic and anthropogenic
in their behavior, as arethe resistance types found in them. Plasmid-
borne resistance, such as CTX-M type ESBL, is obviously rapidly
disseminating since it is already present in high levels in this type of
animal reservoir that the birds represent. Hence, our data together
with other recent studies indicates that birds could act as important
environmental bio-indicators, and reservoirs, of medically impor-
tant pathogens and resistance genes, as well as a potential melting
pot for the development of new resistance types.
Materials and Methods
Collecting of fecal samples
90 samples per colony were collected from juvenile non-fledged
birds. Each sample consisted of a cotton swab that had been
rotated in the cloacae of a bird to obtain fecal material which was
then inoculated into bacterial freeze medium (Luria broth; BD,
Sparks, USA, phosphate buffered saline containing 0.45% Na-
citrate, 0.1% MgSO4, 1% (NH4)2SO4, and 4,4% glycerol). After
sampling in the field, the samples were transported to the
laboratory and frozen at 270uC for later examination.
Bacterial isolation and antibiotic resistance testing
Each sample was plated on Juhlin 32 agar [22] for isolation of
putative E. coli isolates. E. coli identity was confirmed by
biochemical testing. Susceptibility of one isolate per sample (with
75/90 isolated from the ‘‘city dump’’ colony and 78/90 from the
‘‘offshore’’ colony) was tested against a set of antibiotic agents:
tetracycline, ampicillin, streptomycin, chloramphenicol, nalidixic
acid and cefadroxil. These antibiotics were selected to represent
commonly used agents in E. coli infections in human and
veterinary medicine. Susceptibility was determined by antibiotic
disk diffusion on Iso-Sensitest agar (Oxoid, Basingstoke, UK) in
accordance with the recommendations of the Swedish Reference
Group for Antibiotics (SRGA)[22], using E. coli ATCC 25922 as a
reference strain (as in all assessments).
Isolation of ESBL producing bacteria and phenotypic
characterisation
For detection of ESBL producing bacteria, samples were plated
onto on MacConkey agar (Oxoid, Basingstoke, UK) with two
antibiotic discs containing cefotaxime (5 mg) and ceftazidime
(10 mg), respectively. Isolates showing reduced susceptibility to one
or both antibiotics were identified by biochemical testing.
Phenotypic confirmation of ESBL-production was performed by
disc diffusion synergy test according to SRGA [23].Cefepime
MICs were determined using Etest (bioMe ´rieux, Marcy l’Etoile,
France) in isolates with a negative synergy test. ESBL production
was also confirmed with ESBL Etest for cefotaxime, ceftazidime
and cefepime including clavulanic acid (bioMe ´rieux), and growth
on cefpodoxime containing chromID
TM ESBL plates (bioMe ´rieux,
Marcy l’Etoile, France).
Genetic characterization of ESBL producing bacteria
Isolates with ESBL-production were further analyzed for
presence of CTX-M, TEM and SHV type ESBL enzyme genes
(blaCTX-M) using previously described methods [24,25]. The
blaCTX-M gene was sequenced from CTX-M type positive isolates,
using previously described primers [26] and GenScript BacReady
PCR system (GenScript Corporation, Piscataway, NJ).
Multilocus sequence typing of ESBL producing E. coli
isolates
We used the MLST scheme developed by Wirth et al. [11](http://
web.mpiib-berlin.mpg.de), utilizing seven housekeeping genes: ade-
nylate cyclase (adk), fumarate hydratase (fumC), DNA gyrase (gyrB),
isocitrate/isopropylmalate dehydrogenase (icd), malate dehydroge-
nase (mdh), adenylosuccinate dehydrogenase (purA) and ATP/GTP
binding motif (recA). The PCR reactions were as follows; initial
denaturation at 95uC for 2 min, 30 cycles of; denaturation at 95uC
for 1 min; annealing at various temperatures for 1 min; elongation at
72uC for 2 min, and a final elongation at 72uCf o r5m i n .R e a c t i o n s
wereperformedusingaTGradientThermocycler(BiometraGmbH,
Goettinger, Germany). For sequencing reactions a commercially
available sequencing kit was used (Big DyeH Terminator v3.1 cycle
sequencing kit, Applied biosystem, Foster City, CA, USA) and
analyzed in a 3730xl DNA Analyzer (Applied Biosystems, Foster
City, CA, USA) according to manufacturers’ instructions. Primers
sequences and annealing temperatures can be found at http://web.
mpiib-berlin.mpg.de. All sequence traces were imported, aligned,
trimmed and quality controlled aided by functions of the software
Bionumerics v.5.1 (Applied Maths NV, Sint-Martens-Latem, Bel-
gium). Re-sequencing was performed if required and MLST allele
designations were determined via the electronic MLST database at
http://web.mpiib-berlin.mpg.de. Novel ST designations were pro-
vided by the curator of the database (Table 3).
Allele-based population genetic analysis of ESBL
producing E. coli
The genetic relationships of ESBL producing E. coli were
assessed by calculations based on MLST allelic profiles for isolates
Dissemination of CTX-M ESBL
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used the minimum spanning tree algorithm implemented in
Bionumerics v.5.1 (Applied Maths NV) with priority rules set at
first link genotypes that have maximum numbers of single-locus
variants and then maximal numbers of single-locus variants and
double-locus variants. Sequence types (STs) were assigned
members of clonal complex if they shared alleles in six out of
seven house-keeping genes. We choose ST1 to ST278 of the
MLST database as a comparative dataset for analysis of isolates
characterized in this study. ST1 to ST278 represent the known
diversity of E. coli in terms of geography, pathogenicity, human
and animal origins. Four STs of the MLST database were
excluded from analysis since representing extreme outgroup
isolates (ST102, ST125, ST133) or a lack of a phylogentic group
designation (ST103) [11].
Phylogenic analysis of ESBL producing bacteria E. coli
Phylogenetic groups were determined using the triplex PCR
method developed by Clermont et al. [12], and later modified by
addition of subgroups by Escobar-Pa ´ramo et al [13], but with
modified PCR conditions [27].
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